GOLDMAN SACHS GROUP INC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$3,722,956
+6.2%
361,452
+69.9%
0.00%0.0%
Q2 2023$3,506,928
+631.1%
212,799
+306.4%
0.00%
Q1 2023$479,691
+136.6%
52,368
+84.9%
0.00%
Q4 2022$202,757
+28.3%
28,318
-9.9%
0.00%
Q3 2022$158,000
+209.8%
31,444
+51.2%
0.00%
Q2 2022$51,000
-83.4%
20,798
-53.7%
0.00%
Q1 2022$307,000
-33.4%
44,946
-21.2%
0.00%
Q4 2021$461,000
+16.7%
57,003
+41.3%
0.00%
Q3 2021$395,000
+70.3%
40,349
+16.9%
0.00%
Q2 2021$232,000
+29.6%
34,515
+73.8%
0.00%
Q1 2021$179,000
-64.5%
19,854
-73.7%
0.00%
Q4 2020$504,000
+300.0%
75,375
+202.0%
0.00%
Q3 2020$126,000
-96.4%
24,959
-94.3%
0.00%
-100.0%
Q1 2020$3,505,000
+8448.8%
441,440
+2659.0%
0.00%
Q4 2018$41,000
-55.4%
16,000
-23.4%
0.00%
Q3 2018$92,000
-60.0%
20,877
-44.2%
0.00%
Q2 2018$230,000
+19.2%
37,447
+41.3%
0.00%
Q1 2018$193,000
-10.6%
26,510
+0.8%
0.00%
Q4 2017$216,000
-41.5%
26,298
-25.2%
0.00%
Q3 2017$369,000
+0.5%
35,159
+5.7%
0.00%
Q2 2017$367,000
-50.7%
33,271
-56.8%
0.00%
Q1 2017$745,00076,9380.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders